Viewing Study NCT00726557


Ignite Creation Date: 2025-12-24 @ 6:56 PM
Ignite Modification Date: 2026-01-31 @ 7:23 PM
Study NCT ID: NCT00726557
Status: COMPLETED
Last Update Posted: 2015-10-09
First Post: 2008-07-30
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Post-marketing Surveillance Study of Ex-intravenous Drug Abusers With Chronic Hepatitis C Treated With PegIntron Plus Rebetol (P04408/MK-4031-261)
Sponsor: Merck Sharp & Dohme LLC
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hepatitis C, Chronic View
None Substance Abuse, Intravenous View
Keywords: